Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide vs Denosumab for PJK Prevention in ASD Surgery
NCT04241211Phase 4Unknown
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Jan 2014
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of teriparatide in Proximal junctional kyphosis (PJK) (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Incidence of Proximal Junctional Kyphosis at 15 months. Status: unknown.
02
Drugs
teriparatide
03
Conditions
Proximal junctional kyphosis (PJK)
Beyond the preview
Go deeper on NCT04241211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04241211.